| Systematic (IUPAC) name | |
|---|---|
| 3,6α-dihydroxy- 4,5α-epoxy- 7,8-didehydromorphinan | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Schedule I (US) |
| Identifiers | |
| CAS number | 466-97-7 |
| ATC code | None |
| PubChem | CID 430245 |
| IUPHAR ligand | 1630 |
| UNII | XUI1Y24IMI |
| Synonyms | Normorphine |
| Chemical data | |
| Formula | C16H17NO3 |
| Mol. mass | 271.311 g/mol |
| |
|
Normorphine is an opiate analogue, the N-demethylated derivative of morphine, that was first described in the 1950s[1] when a large group of N-substituted morphine analogues were characterized for activity.
Normorphine has relatively little opioid activity in its own right,[2][3] but is a useful intermediate which can be used to produce both opioid antagonists such as nalorphine, and also potent opioid agonists such as N-phenethylnormorphine.[4] It is also produced as a major metabolite of morphine,[5] with its formation from morphine catalysed by the liver enzymes CYP3A4 and CYP2C8.[6]
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)